Product Description
The global syringe and needle market was valued at $4.9 billion in 2025. This is expected to increase over the forecast period at a CAGR of 1.9% to reach $5.6 billion by 2032.
The full report suite on the global syringe and needle market includes two distinct segments: syringes and needles. The syringe segment includes conventional and safety syringes. The needle segment covers conventional needles, safety needles and blunt fill needles.
The report includes data for 65 countries across 7 different regions which include North America, Latin America, Western Europe, Central & Eastern Europe, Middle East, Asia-Pacific, and Africa.
Data Types Included
- Unit Sales, Average Selling Prices, Market Size & Growth Trends
- Market Drivers & Limiters
- Market Forecasts Until 2032, and Historical Data to 2022
- Recent Mergers & Acquisitions
- Company Profiles and Product Portfolios
- Leading Competitors
Global Syringe and Needle Market Trends
Expanded immunization programs and preventive care initiatives continue to support baseline demand for syringes and needles. Routine childhood vaccination schedules, adult booster programs, and targeted immunization campaigns for infectious diseases contribute to sustained high procedure volumes. Public health preparedness and broader access to vaccination services have reinforced the role of conventional injection-based delivery, maintaining consistent demand for standard syringes and needles even as alternative delivery technologies are explored.
Global Syringe and Needle Market Share Insights
- Becton Dickinson led the total syringe and needle market in 2025, leading the hospital segment with over half of segments’ sales. The company’s production scale allowed it to offer syringes at lower costs. BD’s product range included SafetyGlide™ shielding hypodermic needles, Eclipse™ pivoting injection needles and Integra™ retractable syringes.
- Terumo is the second-leading competitor in the global syringes and needles market, supported by a broad portfolio of conventional and safety-engineered injection products. Key brands include Terumo® Syringes, SurGuard® safety needles, and Terumo’s hypodermic needle lines, which are widely used across hospitals, outpatient care, and vaccination programs. The company’s strength lies in high-volume manufacturing, consistent product quality, and strong penetration in Asia-Pacific and other global markets, reinforcing its position in this largely price-driven segment.
- Braun was the third-leading competitor in the total syringe and needle market in 2025. The company has gained significant market share in the past several years, especially in regions such as U.K., France, and Germany. B. Braun manufactures standard and fine-dose two-part and three-part syringes.
Global Syringe and Needle Market Segmentation Summary
- Syringe Market – Further Segmented Into:
- Device Type: Conventional and Safety
- Needle Market – Further Segmented Into:
- Device Type: Conventional, Safety, and Blunt Fill
Research Scope Summary
| Report Attribute | Details |
|---|---|
| Regions | North America (Canada, United States) Latin America (Argentina, Bolivia, Brazil, Chile, Colombia, Costa Rica, Dominican Republic, Ecuador, Guatemala, Mexico, Panama, Paraguay, Peru, Puerto Rico, Uruguay, Venezuela) Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, United Kingdom) Central & Eastern Europe (Azerbaijan, Baltic States, Belarus, Bulgaria, Croatia, Czech Republic, Georgia, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Serbia, Slovakia, Slovenia, Turkey, Ukraine) Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates) Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Kyrgyzstan, Macao, Malaysia, Mongolia, Myanmar, New Zealand, Pakistan, Philippines, Singapore, South Korea, Sri Lanka, Taiwan, Thailand, Uzbekistan, Vietnam) Africa (Algeria, Egypt, Ethiopia, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda) |
| Base Year | 2025 |
| Forecast | 2026-2032 |
| Historical Data | 2022-2024 |
| Quantitative Coverage | Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices. |
| Qualitative Coverage | Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews. |
| Data Sources | Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database. |
CONTACT US FOR ADDITIONAL INFORMATION
For full segmentation and any questions regarding research coverage, please contact us for a complimentary demo of the full report.
